Aneurysm clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
open to eligible people ages 18-80
The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck saccular or fusiform, intracranial aneurysms (IAs) located on the internal carotid artery (ICA) or its branches.
Davis, California and other locations
Our lead scientists for Aneurysm research studies include Ben Waldau, MD, MAS, FAANS, FACS.